Graeme Greenfield

8PUBLICATIONS
23CO-AUTHORS
Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Jul 01, 2021
Molecular pathogenesis of the myeloproliferative neoplasms.

Graeme Greenfield, Mary Frances McMullin, Ken Mills

|Nov 04, 2020
Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort.

Olga Michail, Patrick McCallion, Julie McGimpsey

|Sep 23, 2020
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms.

Graeme Greenfield, Suzanne McPherson, James Smith

|May 11, 2019
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia.

Graeme Greenfield, Ross McMullan, Nuala Robson

|Dec 22, 2018
Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series.

Graeme Greenfield, Mary Frances McMullin

Pageof 2

Frequent Collaborators

3 joint publications

Mary Frances McMullin

2 joint publications

Mark Catherwood

1 joint publications

Chiara Paoli

1 joint publications

Paola Guglielmelli